US Stock MarketDetailed Quotes

WINT Windtree Therapeutics

Watchlist
  • 1.9200
  • -0.1300-6.34%
Close Mar 17 16:00 ET
  • 1.9100
  • -0.0100-0.52%
Post 17:51 ET
424.27KMarket Cap0.00P/E (TTM)

About Windtree Therapeutics Company

Windtree Therapeutics, Inc. is a clinical-stage biopharmaceutical and medical device company engaged in the development of novel therapeutics intended to address significant unmet medical needs in important acute care markets. It focuses on the treatment of acute cardiovascular and acute pulmonary diseases. The company was founded by Evan Myrianthopoulos and James S. Kuo on November 6, 1992 and is headquartered in Warrington, PA.

Company Profile

SymbolWINT
Company NameWindtree Therapeutics
Listing DateAug 8, 1995
Issue Price3.50
Founded1992
CEOMr. Jed A. Latkin
MarketNASDAQ
Employees15
Fiscal Year Ends12-31
Address2600 Kelly Road,Suite 100
CityWarrington
ProvincePennsylvania
CountryUnited States of America
Zip Code18976-3622
Phone1-215-488-9300

Company Executives

  • Name
  • Position
  • Salary
  • Jed A. Latkin
  • Director, President and Chief Executive Officer
  • --
  • Jamie McAndrew
  • Senior Vice President, Principal Accounting Officer and Chief Financial Officer
  • --
  • Eric Curtis
  • Senior Vice President and Chief Operating Officer
  • 451.73K
  • Dr. Steven G. Simonson, M.D.
  • Senior Vice President and Chief Medical Officer
  • 491.73K
  • Craig E. Fraser
  • Chairman of the Board
  • 693.63K
  • Saundra Pelletier
  • Independent Director
  • --
  • Dr. Mark Strobeck, PhD
  • Lead Independent Director
  • 32.34K
  • Leanne M. Kelly
  • Independent Director
  • --

Trending Stocks

Top Gaining Chinese Stocks Top Gaining Chinese Stocks
Unlock Now
Discussing
Tesla's earnings caused fluctuations, what's your market outlook?
Tesla's Q4 2024 revenue was $25.71 billion, up 2% year-on-year but below expectations. Can Tesla's stock price keep rising in 2025 with Trum Show More